Variables | Patients, n (%) |
---|---|
Sex | Â |
 Male | 77 (54.2%) |
 Female | 65 (45.8%) |
Age, years | Â |
 ≤ 65 | 73 (51.4%) |
 > 65 | 69 (48.6%) |
TNM stage | Â |
 I | 26 (18.3%) |
 II | 41 (28.9%) |
 III | 45 (31.7%) |
 IV | 22 (15.5%) |
 Unknown | 8 (5.6%) |
T stage | Â |
 T1 | 7 (4.9%) |
 T2 | 25 (17.6%) |
 T3 | 98 (69.0%) |
 T4 | 11 (7.8%) |
 Unknown | 1 (0.7%) |
N stage | Â |
 N0 | 70 (49.2%) |
 N1 | 40 (28.2%) |
 N2 | 29 (20.4%) |
 N3 | 0 (0.0%) |
 NX | 2 (1.4%) |
 Unknown | 1 (0.7%) |
M stage | Â |
 M0 | 106 (74.6%) |
 M1 | 21 (14.9%) |
 MX | 13 (9.1%) |
 Unknown | 2 (1.4%) |
Follow up time | Â |
 = 0 day or unknown | 7 (4.9%) |
 > 0 day | 135 (95.1%) |